Related references
Note: Only part of the references are listed.iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy
Dominik Brucher et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody
Sheena N. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism
Mattia Deluigi et al.
SCIENCE ADVANCES (2021)
Curative gene therapies for rare diseases
Rocio Maldonado et al.
JOURNAL OF COMMUNITY GENETICS (2021)
Retargeting adenoviruses for therapeutic applications and vaccines
Michael A. Barry et al.
FEBS LETTERS (2020)
Exploiting the folate receptor α in oncology
Mariana Scaranti et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
In vivo gene delivery mediated by non-viral vectors for cancer therapy
Reza Mohammadinejad et al.
JOURNAL OF CONTROLLED RELEASE (2020)
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
Shipo Wu et al.
NATURE COMMUNICATIONS (2020)
Gene delivery for immunoengineering
Sarah Y. Neshat et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness
Dominik Brucher et al.
MABS (2020)
Adenovirus Entry: From Infection to Immunity
Urs F. Greber et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Blood Coagulation Factor X Exerts Differential Effects on Adenovirus Entry into Human Lymphocytes
James S. Findlay et al.
VIRUSES-BASEL (2018)
Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control
Markus Schmid et al.
NATURE COMMUNICATIONS (2018)
Repairing the Brain: Gene Therapy
Tomas Bjorklund
JOURNAL OF PARKINSONS DISEASE (2018)
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Cody S. Lee et al.
GENES & DISEASES (2017)
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
Melissa A. Kotterman et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17 (2015)
Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
Andreas Plueckthun
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
HER2 expression status in diverse cancers: review of results from 37,992 patients
Min Yan et al.
CANCER AND METASTASIS REVIEWS (2015)
Innate Immunity to Adenovirus
Rodinde Hendrickx et al.
HUMAN GENE THERAPY (2014)
Going viral with cancer immunotherapy
Brian D. Lichty et al.
NATURE REVIEWS CANCER (2014)
Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters
Birgit Dreier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2/neu-Expressing Prostate Cancer
M. K. Magnusson et al.
HUMAN GENE THERAPY (2012)
Adenovirus receptors: implications for targeting of viral vectors
Niklas Arnberg
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Targeting Adenoviruses with Factor X-Single-Chain Antibody Fusion Proteins
Christopher Y. Chen et al.
HUMAN GENE THERAPY (2010)
Adenovirus receptors: implications for tropism, treatment and targeting
Niklas Arnberg
REVIEWS IN MEDICAL VIROLOGY (2009)
Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer
Natalya Belousova et al.
JOURNAL OF VIROLOGY (2008)
A designed ankyrin repeat protein evolved to picomolar affinity to Her2
Christian Zahnd et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors
F Kreppel et al.
MOLECULAR THERAPY (2005)
Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors
R Schroers et al.
EXPERIMENTAL HEMATOLOGY (2004)
Genetic retargeting of adenovirus vectors: functionatity of targeting ligands and their influence on virus viability
MK Magnusson et al.
JOURNAL OF GENE MEDICINE (2002)
The development and clinical use of trastuzumab (Herceptin)
M Harries et al.
ENDOCRINE-RELATED CANCER (2002)
Non-viral gene delivery systems
ME Davis
CURRENT OPINION IN BIOTECHNOLOGY (2002)
Hexon gene switch strategy for the generation of chimeric recombinant adenovirus
R Youil et al.
HUMAN GENE THERAPY (2002)
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
MA Kay et al.
NATURE MEDICINE (2001)
Share Paper
